Reply to Blette and Kawut: Surrogate endpoints are risky business in pulmonary arterial hypertension.

Lin S, White RJ, Benza RL

Open source

DOI
10.1093/ajrccm/aamag253
Published
2026 Sep 1
Container
American journal of respiratory and critical care medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ajrccm/aamag253,
  title = {Reply to Blette and Kawut: Surrogate endpoints are risky business in pulmonary arterial hypertension.},
  author = {Lin S and White RJ and Benza RL},
  year = {2026},
  journal = {American journal of respiratory and critical care medicine},
  doi = {10.1093/ajrccm/aamag253},
  url = {https://doi.org/10.1093/ajrccm/aamag253}
}

RIS

TY  - JOUR
TI  - Reply to Blette and Kawut: Surrogate endpoints are risky business in pulmonary arterial hypertension.
AU  - Lin S
AU  - White RJ
AU  - Benza RL
PY  - 2026
JO  - American journal of respiratory and critical care medicine
DO  - 10.1093/ajrccm/aamag253
UR  - https://doi.org/10.1093/ajrccm/aamag253
ER  - 

APA

S, L., RJ, W., & RL, B. (2026). Reply to Blette and Kawut: Surrogate endpoints are risky business in pulmonary arterial hypertension.. American journal of respiratory and critical care medicine. https://doi.org/10.1093/ajrccm/aamag253

Source records